50-155-6909

Menin Polyclonal Antibody, Bethyl Laboratories

Manufacturer: Bethyl Laboratories, Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-155-6909-Each-of-1 In Stock ₹ 12,384.35

50-155-6909 - Each of 1

₹ 12,384.35

In Stock

Quantity

1

Base Price: ₹ 12,384.35

GST (18%): ₹ 2,229.183

Total Price: ₹ 14,613.533

Antigen

Menin

Classification

Polyclonal

Formulation

TBS with 0.1% BSA and 0.09% sodium azide

Gene Accession No.

O00255, O88559

Gene Symbols

MEN1

Immunogen

Between 575 and C-term

Quantity

20 μL

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG

Applications

Immunohistochemistry, Western Blot

Conjugate

Unconjugated

Gene

MEN1

Gene Alias

MEAI, menin, multiple endocrine neoplasia I, SCG2

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

17283, 4221

Content And Storage

4° C

Form

Liquid

Related Products

Img

Bethyl Laboratories, Inc

50-155-6912

--

Img

Bethyl Laboratories, Inc

50-155-6907

--

Img

Bethyl Laboratories, Inc

50-155-6910

--

Img

Bethyl Laboratories, Inc

50-155-6926

--

Img

Bethyl Laboratories, Inc

50-155-6925

--

Img

Bethyl Laboratories, Inc

50-155-7699

--

Img

Bethyl Laboratories, Inc

50-155-7224

--

Img

Bethyl Laboratories, Inc

50-155-7066

--

Description

  • The recommended shelf life for this product is 1 year from date of receipt
  • Application Note: For IHC, epitope retrieval with Tris-EDTA pH 9.0 is recommended for FFPE tissue sections
  • Based on 100% sequence identity, this antibody is predicted to react with Rat, Bovine and Dog Menin is a putative tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1
  • In vitro studies have shown menin is localized to the nucleus, possesses two functional nuclear localization signals, and inhibits transcriptional activation by JunD, however, the function of this protein is not known
  • Two messages have been detected on northern blots but the larger message has not been characterized
  • Two variants of the shorter transcript have been identified where alternative splicing affects the CDS
  • Five variants where alternative splicing takes place in the 5′ UTR have also been identified.